For a deeper look at why dose escalation creates problems long-term, read our post on why higher GLP-1 doses don't always produce better long-term results
Promotion of cell-based therapy: special focus on the cooperation of mesenchymal stem cell therapy and gene therapy for clinical trial studies
The result is a half-life of about 13 hours, requiring once-daily administration instead of once weekly
Members access detailed protocols, expert guidance, and a community of thousands who have navigated these exact questions
Trial results vs real-world expectations Clinical trial results are systematically better than real-world outcomes for several reasons
"For years, we've said 'it's choice, not chance.' That was wrong," Sistani told Axios in an interview